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Objectives: This study aimed to evaluate the frequency of the different alleles of the
VNTR  IL1RN gene (86 bp RP, intron 2), in a Portuguese Caucasian population with implant-
supported overdentures.
Methods: Fifty-eight Caucasians rehabilitated with implant overdentures for at least
6  months, were randomly recruited from the Removable Prostheses Forms used in Faculty of
Dental Medicine, University of Porto. After clinical examination, DNA was obtained through
oral mucosa swab. PCR was used to identify the IL1RN gene alleles. The frequency estimates
and  the corresponding 95% CI for alleles and genotypes of the IL1RN gene were calculated
using the exact binomial test.
Results: The population included 44 females and 14 males. Only 2 subjects were smokers;
6  subjects had diabetes and 5 had chronic gastritis. The most frequent allele of IL1RN gene
was allele 5, with an estimated frequency of 58.6%, followed by the allele 4 with a frequency
of  48.3%. The alleles 1 and 2 were not detected. The most frequent genotype was allele
5/allele 5, followed by the allele 4/allele 4.
Conclusions: Allele 5 was the most frequent IL1RN allele and allele 5/allele 5 was the most
frequent genotype. Further studies are required in order to understand the role of alleles
5  and 4, as well as of the allelic combinations of the IL1RN gene polymorphism, on the
development of biological complications with dental implants.© 2015 Sociedade Portuguesa de Estomatologia e Medicina Dentária. Published byElsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Polimorﬁsmos  do  gene  IL1RN  numa  populac¸ão  Portuguesa  com
sobredentaduras  implanto-suportadas  –  um  estudo  observacional
Palavras-chave:
Implantes dentários
Polimorﬁsmos genéticos
Interleucina 1
IL1RN
r  e  s  u  m  o
Objetivos: Este estudo teve como objetivo avaliar a frequência dos diferentes alelos do gene
IL1RN VNTR (86 bp, intrão 2), numa populac¸ão Caucasiana Portuguesa com sobredentaduras
implanto-suportadas.
Métodos: Cinquenta-e-oito caucasianos reabilitados com sobredentaduras implantares por
pelo menos 6 meses, foram recrutados aleatoriamente dos formulários de Prótese Removível
da Faculdade de Medicina Dentária da Universidade do Porto. Após exame clínico, o ADN foi
obtido por esfregac¸o da mucosa oral. A técnica PCR foi utilizada para identiﬁcar os alelos do
gene  IL1RN. A estimativa da frequência e respetivos IC a 95% dos alelos e genótipos IL1RN
foram calculados usando o teste binomial exato.
Resultados: A populac¸ão incluiu 44 mulheres e 14 homens. Apenas e indivíduos eram
fumadores; 6 indivíduos apresentavam diabetes e 5 apresentavam gasrite crónica. O alelo 5
foi  o alelo mais frequente do gene IL1RN, com uma frequência estimada de 58,6%, seguido
do  alelo 4 com uma frequência de 48,3%. Os alelos 1 e 2 não foram detetados. O genótipo
mais  frequente foi alelo 5/alelo 5, seguido de alelo 4/alelo 4.
Conclusões: O alelo 5 foi o alelo mais frequente do gene IL1RN e alelo 5/alelo 5 foi o genótipo
mais frequente. São necessários mais estudos para se compreender o papel dos alelos 5 e 4,
bem como das combinac¸ões de alelos do polimorﬁsmo do gene IL1RN, no desenvolvimento
de  complicac¸ões biológicas com implantes dentários.
©  2015 Sociedade Portuguesa de Estomatologia e Medicina Dentária. Publicado por
Elsevier España, S.L.U. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Oral rehabilitation with dental implants has become increas-
ingly relevant, given the evolution and diversity of the existing
implant systems and their accessibility to the population. In
general, dental implant rehabilitation can provide predictable
and lasting results in the replacement of missing teeth and
preservation of the adjacent natural tooth structures.1–5
Oral implants have become a widespread practice and their
popularity will probably increase in the next few years.6 Con-
sequently, cases of peri-implant complications and implant
failure tend to increase.7 The clinical observation of repeti-
tive unsuccessful dental implants in certain individuals has
raised some questions related to host susceptibility to dental
implant failure.8 Several risk factors for implant failure were
pointed out: hypertension, cardiovascular diseases, diabetes,
autoimmune disorders, osteoporosis, bisphosphonate ther-
apy, radiotherapy, history of periodontitis, smoking, implant
site bone quality and genetic traits.9 In fact, in a speciﬁc
group of individuals, some speciﬁc host characteristics, which
may disturb the osseointegration process, were suggested to
be inﬂuenced by genetic factors.8,10,11 Moreover, the number,
identity and role of regulatory factors that can determine and
maintain the success of osseointegration process are still a
mystery.9
Nowadays, genetics research is concerned with studying
DNA sequence variations (polymorphisms) and potentially
associating them with increased risks for developing a par-
ticular condition or disease by a restricted population. In fact,
these DNA variations may condition the gene transcription(http://creativecommons.org/licenses/by-nc-nd/4.0/).
rate, the messenger RNA stability, or even the amount and
activity of the produced protein.12
In the last years, several studies have pointed out the
impact of certain interleukin-1 (IL1) gene single nucleotide
polymorphisms (SNP) in the host response and in the devel-
opment of peri-implant biological complications.6,8,13–21
More recently, some authors have suggested the existence
of a possible relationship between an 86 bp (base pairs) repeat
polymorphism (a variable number tandem repeat, VNTR) in
intron 2 of the interleukin-1 receptor antagonist gene (IL1RN)
and the development of biological implant complications,
such as implant loss and peri-implantitis.11,22,23
Interleukin-1 (IL1) is a potent proinﬂammatory mediator
mainly released by monocytes, macrophages, and dendritic
cells, against microbial pathogens. This action is induced by
lipopolysaccharides from gram-negative bacteria, present in
the peri-implant sulcus. The interleukin-1 protein has two  dis-
tinct structural forms encoded in two different genes – alpha
in IL1A and beta in IL1B – located in the same chromosome 2
(2q13–q21).24
The interleukin-1 receptor antagonist (IL1RN) is a cytokine
that binds to IL1 receptors, inhibiting their connection with
IL1A and IL1B. Thus, the IL1RN molecule competes with IL1A
and IL1B in target cells and acts as a negative regulator, with
an anti-inﬂammatory effect. The IL1RN gene is also located in
chromosome 2 (2q14.2).25
The reported VNTR of the IL1RN gene (intron 2) includes a
variation of 2–6 repeats (RP), which results in 5 different alleles:
4 RP for allele 1, 2 RP for allele 2, 3 RP for allele 3, 5 RP for allele
4 and 6 RP for allele 5. Allele 1 was reported as the most com-
mon  of these alleles, followed by allele 2. The remaining alleles
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Figure 1 – Buccal swab and collection of biological sample
tics 22.0 and with the R 3.1.1. software (R Core Team 2014).
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ere considered less frequent. Most individuals were found to
e homozygous for allele 1 IL1RN or heterozygous for allele 1
nd allele 2 IL1RN.  Allele 2 IL1RN is characteristically found in
omozygosity in less than 10% of the general population.26
Allele 2 IL1RN has been associated with a reduced pro-
uction of the IL1RN protein and with inﬂammatory process
ncrease.27,28 Additionally, an association of this allele with an
ncreased in vitro IL1B production was reported.29
In this regard, many  studies concerning the presence of the
NTR IL1RN gene and the individual susceptibility to autoim-
une diseases, chronic inﬂammatory diseases, cancer, and
acterial and virus infections were conducted.30 Among the
tudied conditions, the following should be highlighted: lupus
rythematosus,31 multiple sclerosis,32 inﬂammatory bowel
isease,33 gastric cancer,34 tuberculosis35 and Epstein–Barr
irus infection.36
Although there are few studies in the literature
egarding the VNTR IL1RN gene and biological implant
omplications,11,22,23 these point out an association between
llele 2 of the IL1RN gene and bone loss or peri-implantitis.
This study aimed to evaluate the frequency of the different
lleles of the VNTR IL1RN gene polymorphism (86 bp RP, intron
), in a Portuguese Caucasian population rehabilitated with
ental implant overdentures.
ethods
he study was outlined according to the established legal
orms (Helsinki Declaration; Additional Protocol to the Con-
ention on Human Rights and Biomedicine–Strasbourg 2005;
aw No. 12/2005), and the research protocol was approved by
he Ethical Committee of the Faculty of Dental Medicine of the
niversity of Porto (Portugal). All included patients gave their
nformed consent to participate in the present study.
Fifty-eight Portuguese Caucasian unrelated individuals,
ehabilitated with implant-supported overdentures during at
east 6 months (inclusion criteria), were randomly selected
rom the Removable Prostheses Forms used in the Masters
nd Specialization in Oral Rehabilitation of the Faculty of Den-
al Medicine, University of Porto, during the period between
eptember 2012 and September 2014. The exclusion crite-
ia were changes or loss of the implant rehabilitation, and
regnant, postpartum or breastfeed women.
The sample size was calculated based on a statistical esti-
ate, with a 95% conﬁdence interval and an associated error
f 6.1%. The minimum number of individuals was deter-
ined according to the reported frequency of the most studied
nterleukin-1 gene polymorphisms in European Caucasian
opulations8,37,38 and the incidence rate of 6% for biological
omplications in implant rehabilitations.10,39–46
For each patient, clinical history collection concerning gen-
ral and oral health, a clinical examination involving implant,
cclusal and prosthetic evaluation, and a biological sample
ollection were carried out. The latter was performed using
terile and decontaminated DNA buccal swabs (Fig. 1), pro-
ided by the laboratory responsible for processing the samples
CGC Genetics/Genetic Centre Clinic SA, Portugal). The DNA
xtraction was performed using the QIAsymphonyDNA Mini
it in the QIAsymphony equipment (QIAGEN®, Germany).(FLOQSwabsTM COTAN Flock Technologies).
After the DNA extraction, its ampliﬁcation was accom-
plished, and the ﬁve alleles of the IL1RN gene were identiﬁed
by Polymerase Chain Reaction (PCR). The primer used and the
classiﬁcation of IL1RN alleles are presented in Table 1. Veriﬁca-
tion and quantiﬁcation of PCR products (Fig. 2) were performed
in agarose gel using the QIAxcel equipment (QIAGEN®, Ger-
many).
The collected data were analyzed with IBM® SPSS® Statis-Figure 2 – Electrophoretic representation of PCR products
and detection of alleles 3, 4 or 5 of IL1RN.
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Table 1 – IL1RN gene polymorphism identiﬁcation.
Polymorphism Primer PCR 5′ → 3′ Alleles (no. repeats/bp)
Allele 1 Allele 2 Allele 3 Allele 4 Allele 5
IL1RN VNTR TCC  TGG TCT GCA GGT AA 4/410 2/240 3/326 5/498 6/595
CTC AGC AAC ACT CCT AT
No. repeats: number of repeats, bp: base pair.
Table 2 – Sample characterization and allelic distribution for IL1RN gene polymorphism.
Total IL1RN  allele frequency (N)
N % Allele 1 Allele 2 Allele 3 Allele 4 Allele 5
Gender
Male 14 24.1 0 0 0 8 9
Female 44 75.9 0 0 6 20 25
Smoking
Non-smokers 56 96.6 0 0 6 27 32
Smokers 2 3.4 0 0 0 1 2
Systemic diseases
Diabetes 6 10.4 0 0 1 2 3
Chronic gastritis 5 8.6 0 0 1 3 3
 samN: number of subjects in the sample; %: percentage of subjects in the
The frequency estimates and the corresponding 95% CI
(conﬁdence interval) for alleles and genotypes of the IL1RN
gene were calculated using the exact binomial test.
Results
The patients’ ages ranged between 50 and 86 years old
(mean 68.8 ± 8.3) and none presented genetic disease or family
genetic disease. The sample characterization and allelic dis-
tribution for IL1RN gene polymorphism is presented in Table 2.
Our population included 75.9% female and 24.1% male. Only
Allele 4 IL1RN
Allele 5 IL1RN
Allele 3 IL1RN
Allele 2 IL1RN
Allele 1 IL1RN 0.0%
0.0%
10.3%
48.3%
5
Figure 3 – Allelic distribution of IL1RN geneple.
2 subjects were smokers and few patients had systemic dis-
eases (6 with diabetes and 5 with chronic gastritis).
In this Portuguese Caucasian population with implant-
supported overdentures, the most frequent allele of the IL1RN
gene was allele 5, with an estimated frequency of 58.6% and a
CI between 44.9% and 71.4%. The second most frequent allele
of the IL1RN gene was allele 4, presenting an estimated fre-
quency of 48.3% (CI between 33.9% and 61.8%), followed by
allele 3 with an estimated frequency of 10.3% (CI between
3.9% and 21.2%). It should be noted that alleles 1 and 2
of the IL1RN gene were not detected in the present study
(Fig. 3).
8.6%
 polymorphism in the sample (N = 58).
r e v p o r t e s t o m a t o l m e d d e n t c i r m
Table 3 – Genotype distribution for IL1RN gene
polymorphism in the sample (N = 58).
IL1RN genotype % 95% CI
Allele 3/allele 3 5.2 1.1–14.4
Allele 3/allele 4 5.2 1.1–14.4
Allele 4/allele 4 31.0 19.5–44.5
Allele 4/allele 5 12.1 5.0–23.3
Allele 5/allele 5 46.6 33.3–60.1
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in women and the allele2 was more  frequent in men. This%: estimated frequency, CI: conﬁdence interval at 95%.
Table 3 shows the genotype frequencies (allelic combina-
ions) of the IL1RN gene polymorphism found in the study
ample. From the 15 total possible genotype combinations of
he VNTR IL1RN gene, ﬁve allelic combinations were identiﬁed:
llele 3/allele 3, allele 3/allele 4, allele 4/allele 4, allele 4/allele
 and allele 5/allele 5. The remaining genotype combinations,
rom the 15 possible, were not detected in the studied sample
allele 1/allele 1, allele 1/allele 2, allele 1/allele 3, allele 1/allele
, allele 1/allele 5, allele 2/allele 2, allele 2/allele 3, allele 2/
llele 4, allele 2/allele 5 and allele 3/allele 5).
The most frequently found genotypes for the IL1RN gene
olymorphism, in a Portuguese Caucasian population with
mplant-supported overdentures, were allele 5/allele 5, fol-
owed by allele 4/allele 4. Together, the allelic combinations
llele 5/allele 5 and allele 4/allele 4 account for more  than 75%
f the sample.
Table 4 summarizes the biological complications and the
L1RN allele and genotype distributions. It is noted a tendency
oward an association between mucositis and peri-implantitis
nd the allelic combination 4/4 and 5/5.
iscussion
he interleukin-1 superfamily includes some of the most
mportant cytokines involved in host-pathogen immune
esponse. The IL1A and IL1B act as potent proinﬂammatory
olecules and the IL1RN (antagonist of the receptor of IL1) has
Table 4 – Biological complications and IL1RN gene polymorphis
IL1RN allele3 IL1RN allele4 
Absent Present Absent Presen
Erythema Absent 36 2 19 19 
Present 16 4 11 9 
Supuration Absent 48 5 29 24 
Present 4 1 1 4 
Fistula Absent 51 6 30 27 
Present 1 0 0 1 
Mobility/pain Absent 51 6 30 27 
Present 1 0 0 1 
Mucositis Absent 31 2 19 14 
Present 21 4 11 14 
Peri-implantitis Absent 36 4 21 19 
Present 16 2 9 9 
Early implant loss Absent 43 6 25 24 
Present 9 0 5 4 
Late implant loss Absent 51 5 28 28 
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an anti-inﬂammatory role, avoiding the transmission of proin-
ﬂammatory signals and preventing the immune response.
Bone is a tissue in continuous remodeling, through appo-
sition and resorption, mediated by the local production of
inﬂammatory cytokines, such as IL1B and IL1RN. IL1B con-
tributes to bone resorption and IL1RN inhibits IL1B activity
through competitive binding to the IL1B receptor, thus sup-
pressing the IL1B induction of cytokine.6,8,21
The polymorphisms found in the IL1B (+3954) and IL1RN
(intron 2) genes may account for variations in the IL1B and
IL1RN proteins. Allelic variation in the IL1RN gene could be
expected to have an impact on inﬂammatory processes and
on the occurrence of biological complications, such as implant
loss or peri-implantitis.11,23
The number of 86 bp RP present in the intron 2 IL1RN gene
may be of functional signiﬁcance, as the sequence contains
three potential protein-binding sites: an alpha-interferon
silencer A, a beta-interferon silencer B, and an acute phase
response element. The alpha-interferon silencer A acts as a
repressor of viral response, when 4 RP (allele 1) are positioned
between an enhancer and a promoter. The 2 RP (allele 2) were
reported as inactive or very weakly active in the viral response.
The beta-interferon silencer B and the acute phase response
element are also contained within the viral response element,
in the human beta-interferon gene response.26 Since individ-
uals with different copy numbers of the 86 bp repeat sequence
in the IL1RN gene intron 2 have correspondingly different
numbers of these protein-binding agents, these individuals
should, hypothetically, exhibit different functional effects of
the polymorphism.
In our study, alleles 5 and 4 were the most frequent, present
in 58.6% and 48.3% of the sample, respectively. Also, there are
not differences on the frequency of these two alleles, accord-
ing to the gender (Table 2).
In the study of Bessler et al., allele1 was more  prevalent
12difference was also expressed by a higher incidence of the
genotype combination allele1/allele1 in men  compared with
women. These results are different from ours probably due
m.
IL1RN allele5 Genotype IL1RN
t Absent Present 3/3 3/4 4/4 4/5 5/5
15 23 1 1 13 5 18
9 11 2 2 5 2 9
21 32 3 2 16 6 26
3 2 0 1 2 1 1
24 33 3 3 18 6 27
0 1 0 0 0 1 0
23 34 3 3 17 7 27
1 0 0 0 1 0 0
10 23 1 1 8 5 18
14 11 2 2 10 2 9
16 24 2 2 12 5 19
8 10 1 1 6 2 8
21 28 3 3 15 6 22
3 6 0 0 3 1 5
23 33 2 3 18 7 26
1 1 1 0 0 0 1
t c i r
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to the genetic characteristic, size and gender distribution.
In that study12 319 healthy subjects had two Jewish origins
(45.8% Ashkenazi of European descent, 48.9% Sepharadic)
and the gender distribution was equilibrated (156 women,
163 men). In our study, all 58 patients were Caucasians,
with more  women than men, probably due to the selection
method.
Our allele prevalence results are not similar to those
presented in other investigations performed in populations
rehabilitated with dental implants.11,22,23
In the study performed by Campos et al., the most
frequent alleles were alleles 1 and 2. The frequency of
allele 4 was 1.4% in a control group (Brazilian patients
with successful implants) and 1.7% in a test group (Brazil-
ian patients with failed implants).22 The difference between
these results and the ones presented in our research proba-
bly reﬂect the miscegenation of the Brazilian population in
comparison with the more  homogeneous Portuguese popula-
tion.
In the work of Laine et al., allele 2 showed a frequency
of 34.8% in the case group (patients with peri-implantitis)
and of 21.9% in the control group (patients without signs
of peri-implant disease).23 That research was conducted to
evaluate the role of allele 2 in peri-implantitis and does
not mention the individual frequencies of the other four
alleles of the IL1RN gene. Also, that study’s design (case
and control groups) and sample (Caucasian individuals from
Northern Europe) were different from the ones presented
in our study, which probably justiﬁes the results of each
study.
Regarding the results obtained by Montes et al., those can-
not be compared to ours, because that study evaluated the
frequency of an allele “X”, which included the presence of
alleles 1, 3, 4 or 5, and of allele 2 in the IL1RN gene. There-
fore, the most frequent allele was allele “X” in a control group
(patients with no multiple implant losses), present in 75%
cases and in 61% of the cases of a test group (patients with
multiple dental implant losses).11
Considering the biological complications, our results show
a tendency toward an association between mucositis and peri-
implantitis and the allelic combination 4/4 and 5/5, which are
different from the studies aforementioned11,22,23 probably due
to the study design and the population characteristics.
The study limitations are the sample size and the differ-
ences in number of individuals based on gender.
Conclusion
The most frequent allele of the IL1RN gene polymorphism was
allele 5, with an estimated frequency of 58.6% (CI 44.9–71.4%)
in a Portuguese Caucasian population with implant-supported
overdentures. Alleles 1 and 2 were not detected in the present
study.
The estimated frequency of the allele 5/allele 5 combina-
tion for the VNTR (intron 2) of the IL1RN gene polymorphism
was 46.6% (CI 33.3–60.1%) and for the allele 4/allele 4 combi-
nation was 31.0% (CI 19.5–44.5%).
Further studies are required in order to understand the role
of alleles 5 and 4, as well as of the allelic combinations of the m a x i l o f a c . 2 0 1 5;5  6(4):207–214
IL1RN gene polymorphism, on the development of biological
complications with dental implants.
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